Search for: "AMGEN INC." Results 481 - 500 of 704
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Mar 2012, 6:52 am by Bexis
Amgen (IDE Embrel) Deposition2005-06-10 Saban v. [read post]
7 Feb 2012, 2:19 pm by info@thomasjhenrylaw.com
Amgen Inc.'s cancer drug Xgeva is up for review by the FDA's oncologic drugs advisory committee this Wednesday as the manufacturer aims to expand its uses. [read post]
22 Jan 2012, 5:31 pm by admin
” In urging the First Circuit to revive the case, the amicus brief also indicates that the First Circuit recently reopened similar qui tam cases against Amgen Inc. and Blackstone Medical Inc. that alleged kickbacks. [read post]
13 Jan 2012, 8:59 pm by Patent Docs
A panel consisting of Ned Israelsen of Knobble Martens Olson & Bear, LLP; Stuart Watt of Amgen Inc.; and Harold Wegner of Foley & Lardner, LLP will: • Give recommendations on how companies can restructure their invention disclosure and priority filing systems, including consideration of trade secret protection; • Consider how the new U.S. first-to-file system will be different than those that now exist internationally, and how those differences should be dealt… [read post]
26 Dec 2011, 7:57 pm by A. Brian Albritton
"  Health Policy previously highlighted two petitions for certiorari filed this fall that sought to bring this matter to the Supreme Court:  Amgen Inc. et al., v. [read post]
5 Dec 2011, 7:24 pm by Nicole Huberfeld
  So, even if the Court does not grant the petition in the other FCA case on the docket (Amgen, Inc. v. [read post]
2 Dec 2011, 2:00 pm by Kiera Flynn
Susan HutchesonDocket: 11-269Issue(s): (1) Whether an allegation that a defendant has committed a statutory violation renders a claim submitted by an unrelated party “legally false” for purposes of the FCA, where no statute or regulation expressly conditions payment of the unrelated party’s claim on the defendant’s compliance; and (2) whether and when a private citizen is authorized to use a “legally false” theory under the False Claims Act as a generalized… [read post]
18 Nov 2011, 6:58 am
Amgen et al., it was also the basis for a securities lawsuit alleging that a retirement investor was misled by public statements made by Amgen Inc. and four of its officers about the anemia drugs Aranesp and Epogen. [read post]
14 Nov 2011, 4:21 pm by Lori Bauman
Amgen, Inc., the plaintiff alleged that misstatements and failure to disclose by defendants illegally inflated the value of Amgen stock. [read post]